Hap Trading, LLC Teva Pharmaceutical Industries LTD Call Options Transaction History

Hap Trading, LLC

$840 Billion
Q2 2024

Call Options

23 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2023 Nov 09, 2023	SELL	$7.48 - $10.7 $164,560 - $235,399	-22,000 Reduced 63.95%	12,400 $126,000
Q2 2023 Aug 11, 2023	BUY	$7.2 - $9.47 $247,680 - $325,768	34,400 New	34,400 $259,000
Q4 2022 Feb 14, 2023	BUY	$7.95 - $9.48 $115,275 - $137,460	14,500 Added 19.54%	88,700 $21,000
Q3 2022 Nov 14, 2022	BUY	$6.86 - $11.95 $148,862 - $259,314	21,700 Added 41.33%	74,200 $9,000
Q2 2022 Aug 12, 2022	BUY	$7.38 - $10.4 $274,536 - $386,880	37,200 Added 243.14%	52,500 $5,000
Q1 2022 May 12, 2022	SELL	$7.33 - $9.39 $392,888 - $503,304	-53,600 Reduced 77.79%	15,300 $8,000
Q4 2021 Feb 14, 2022	SELL	$7.9 - $10.19 $368,140 - $474,854	-46,600 Reduced 40.35%	68,900 $6,000
Q3 2021 Nov 10, 2021	BUY	$8.38 - $10.18 $289,948 - $352,228	34,600 Added 42.77%	115,500 $27,000
Q2 2021 Aug 11, 2021	BUY	$9.9 - $11.56 $800,910 - $935,204	80,900 New	80,900 $11,000
Q1 2021 May 14, 2021	SELL	$10.34 - $12.81 $3.85 Million - $4.77 Million	-372,300 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$8.61 - $11.04 $3.21 Million - $4.11 Million	372,300 New	372,300 $109,000
Q3 2020 Nov 13, 2020	SELL	$8.57 - $12.69 $1.05 Million - $1.56 Million	-122,800 Closed	0 $0
Q2 2020 Aug 10, 2020	BUY	$8.12 - $13.12 $997,135 - $1.61 Million	122,800 New	122,800 $173,000
Q4 2019 Feb 11, 2020	SELL	$6.53 - $10.72 $3.93 Million - $6.45 Million	-601,600 Closed	0 $0
Q3 2019 Nov 12, 2019	BUY	$6.16 - $9.6 $2.62 Million - $4.09 Million	425,600 Added 241.82%	601,600 $70,000
Q2 2019 Aug 14, 2019	SELL	$8.12 - $15.72 $1.27 Million - $2.45 Million	-156,100 Reduced 47.0%	176,000 $34,000
Q1 2019 May 10, 2019	BUY	$15.58 - $20.01 $2.37 Million - $3.05 Million	152,300 Added 84.71%	332,100 $65,000
Q4 2018 Feb 12, 2019	SELL	$14.59 - $23.84 $644,878 - $1.05 Million	-44,200 Reduced 19.73%	179,800 $42,000
Q3 2018 Nov 09, 2018	BUY	$21.06 - $25.65 $617,058 - $751,545	29,300 Added 15.05%	224,000 $137,000
Q2 2018 Aug 13, 2018	BUY	$16.77 - $24.71 $2.32 Million - $3.42 Million	138,500 Added 246.44%	194,700 $298,000
Q1 2018 May 11, 2018	SELL	$16.68 - $22.07 $505,404 - $668,721	-30,300 Reduced 35.03%	56,200 $45,000
Q4 2017 Feb 09, 2018	BUY	$11.23 - $19.1 $278,504 - $473,680	24,800 Added 40.19%	86,500 $91,000
Q3 2017 Nov 08, 2017	BUY	$15.41 - $32.17 $950,797 - $1.98 Million	61,700	61,700 $33,000

Others Institutions Holding TEVA

# of Institutions

624

Shares Held

565M

Call Options Held

25.2M

Put Options Held

5.08M

Black Rock Inc. New York, NY

43M
Shares

$736 Million
0.02% of portfolio
Ion Asset Management Ltd. George Town, Grand Cayman, E9

36.3M
Shares

$622 Million
41.14% of portfolio
Clal Insurance Enterprises Holdings LTD Tel Aviv, L3

32.3M
Shares

$553 Million
5.5% of portfolio
Menora Mivtachim Holdings Ltd.

28.8M
Shares

$493 Million
3.23% of portfolio
Exor Capital LLP London, X0

26.5M
Shares

$453 Million
15.49% of portfolio

View Full List

About TEVA PHARMACEUTICAL INDUSTRIES LTD

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $19B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

More about TEVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hap Trading, LLC with notifications on news.

Account